Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-arm, Multicenter, Phase IV Study to Evaluate the Response to Treatment and Safety of Flexible Dose Treatment With Extended-release Paliperidone in Patients With Schizophrenia

NCT00915512 is registered in ClinicalTrials.gov with Janssen-Cilag Turkey as lead sponsor.

NCT NCT00915512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00915512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-arm, Multicenter, Phase IV Study to Evaluate the Response to Treatment and Safety of Flexible Dose Treatment With Extended-release Paliperidone in Patients With Schizophrenia
Lead sponsor
Janssen-Cilag Turkey
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
October 31, 2011
Enrollment
84 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia